What Are Maintenance Inhalers for Asthma and How Do They Work? | Daily Control

Maintenance inhalers are daily controller medicines that calm airway inflammation and help prevent asthma symptoms and attacks.

Using one during an asthma attack is a common, unsafe mistake — most controller inhalers act too slowly to help. They are built for daily prevention: delivering a small dose of controller medicine to the airways every day, cutting the inflammation that would otherwise build into wheezing and attacks.

Here is what separates the main controller categories, which products carry US approval, and when one inhaler handles both daily control and symptom relief.

What Do Maintenance Inhalers Do For Asthma?

The controller is usually an inhaled corticosteroid (ICS), alone or combined with a long-acting beta agonist (ICS/LABA).

ICS-only inhalers handle the anti-inflammatory job alone. ICS/LABA combinations add a long-acting bronchodilator; versions built around formoterol are used in maintenance-and-reliever therapy (MART), because formoterol starts working fast enough to double as symptom relief.

Daily use is the point. A controller taken only on rough days cannot hold inflammation down, and the Global Initiative for Asthma ties MART to patients with more frequent symptoms or poor control on simpler regimens.

Outside a MART plan, a maintenance inhaler is not a rescue inhaler. Most controllers act too slowly for sudden symptoms, and FDA labeling for fluticasone propionate inhalation aerosol warns against using it as primary treatment for status asthmaticus or other severe acute episodes.

Maintenance Inhaler Options: What The Labels Cover

US-labeled maintenance options differ by active ingredient, age range, and dosing schedule. A prescription decides which one fits; the labels set the boundaries.

ArmonAir RespiClick, an ICS containing fluticasone propionate, is approved for asthma maintenance in patients 12 years and older.

AirDuo RespiClick is approved for adolescent and adult asthma patients in 55/14 mcg, 113/14 mcg, and 232/14 mcg strengths, taken as one inhalation twice daily, per the FDA’s approval of a combination asthma treatment.

Budesonide-formoterol arrives in 80/4.5 and 160/4.5 strengths with a generic option. The 80/4.5 version can be used as single-inhaler maintenance and reliever therapy — 1 to 2 puffs once or twice daily, then every 4 hours as needed. If you are weighing devices before a pharmacy visit, this tested roundup of asthma maintenance inhalers walks through what each one is like to use.

How Do You Use A Maintenance Inhaler Correctly?

Take it every day exactly as prescribed, even when breathing feels fine — consistency keeps inflammation from rebuilding, and skipping the good days undoes the benefit.

When the prescription is MART, one inhaler covers both roles: the same ICS-formoterol inhaler daily as prescribed, plus extra doses when symptoms appear. For acute or severe symptoms, guidance advises that a course of oral corticosteroids may be needed alongside acute treatment. A maintenance inhaler should not be relied on for rapid relief unless specifically prescribed for AIR/MART use with formoterol.

Most trouble traces back to two habits: treating a controller as a rescue inhaler, and assuming any ICS/LABA combination can stand in for MART — guidance centers maintenance-and-reliever therapy on ICS-formoterol combinations, not the whole category.

Availability is not universal. MART and SMART terminology comes largely from UK and Australian guidance — NICE describes AIR/MART pathways for people needing inhaled-steroid-based treatment — and qualifying inhalers differ by country and formulary, so a US plan may look different from one described overseas.

A routine that holds up looks like this:

1. Take the daily dose at the same times every day, including stretches when breathing feels normal.
2. Keep the prescribed rescue inhaler within reach unless the plan is MART.
3. If MART was prescribed, use the same ICS-formoterol inhaler for symptom doses and track how often you need it.
4. Contact your clinician if symptoms are climbing, since a short course of oral corticosteroids may be needed.